Literature DB >> 30192374

Castration remains despite decreasing definitive treatment of localized prostate cancer in the elderly: A case for de-implementation.

Ted A Skolarus1,2, Megan Ev Caram1,3, Christina H Chapman1,4, David C Smith3, Brent K Hollenbeck2, Sarah Hawley1,5, Alexander Tsodikov6, Anne Sales1,7, Daniela Wittmann2, Alexander Zaslavsky2.   

Abstract

Entities:  

Year:  2018        PMID： 30192374      PMCID： PMC6812568          DOI： 10.1002/cncr.31665

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  14 in total

1.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

2.  Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.

Authors:  Urs E Studer; Peter Whelan; Walter Albrecht; Jacques Casselman; Theo de Reijke; Dieter Hauri; Wolfgang Loidl; Santiago Isorna; Subramanian K Sundaram; Muriel Debois; Laurence Collette
Journal:  J Clin Oncol       Date:  2006-04-20       Impact factor: 44.544

3.  Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.

Authors:  Grace L Lu-Yao; Peter C Albertsen; Dirk F Moore; Weichung Shih; Yong Lin; Robert S DiPaola; Siu-Long Yao
Journal:  JAMA Intern Med       Date:  2014-09       Impact factor: 21.873

4.  Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.

Authors:  Michael T Schweizer; Emmanuel S Antonarakis; Hao Wang; A Seun Ajiboye; Avery Spitz; Haiyi Cao; Jun Luo; Michael C Haffner; Srinivasan Yegnasubramanian; Michael A Carducci; Mario A Eisenberger; John T Isaacs; Samuel R Denmeade
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

5.  Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer.

Authors:  Arnold L Potosky; Reina Haque; Andrea E Cassidy-Bushrow; Marianne Ulcickas Yood; Miao Jiang; Huei-Ting Tsai; George Luta; Nancy L Keating; Matthew R Smith; Stephen K Van Den Eeden
Journal:  J Clin Oncol       Date:  2014-03-17       Impact factor: 44.544

6.  Physician visits prior to treatment for clinically localized prostate cancer.

Authors:  Thomas L Jang; Justin E Bekelman; Yihai Liu; Peter B Bach; Ethan M Basch; Elena B Elkin; Michael J Zelefsky; Peter T Scardino; Colin B Begg; Deborah Schrag
Journal:  Arch Intern Med       Date:  2010-03-08

7.  Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Authors:  C Huggins; C V Hodges
Journal:  CA Cancer J Clin       Date:  1972 Jul-Aug       Impact factor: 508.702

8.  Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer.

Authors:  David D Yang; Brandon A Mahal; Vinayak Muralidhar; Ninjin Boldbaatar; Shelby A Labe; Michelle D Nezolosky; Marie E Vastola; Clair J Beard; Neil E Martin; Kent W Mouw; Peter F Orio; Martin T King; Paul L Nguyen
Journal:  Cancer       Date:  2017-08-22       Impact factor: 6.860

9.  Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Authors:  Anders Widmark; Olbjørn Klepp; Arne Solberg; Jan-Erik Damber; Anders Angelsen; Per Fransson; Jo-Asmund Lund; Ilker Tasdemir; Morten Hoyer; Fredrik Wiklund; Sophie D Fosså
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321

10.  American Cancer Society prostate cancer survivorship care guidelines.

Authors:  Ted A Skolarus; Andrew M D Wolf; Nicole L Erb; Durado D Brooks; Brian M Rivers; Willie Underwood; Andrew L Salner; Michael J Zelefsky; Jeanny B Aragon-Ching; Susan F Slovin; Daniela A Wittmann; Michael A Hoyt; Victoria J Sinibaldi; Gerald Chodak; Mandi L Pratt-Chapman; Rebecca L Cowens-Alvarado
Journal:  CA Cancer J Clin       Date:  2014-06-10       Impact factor: 508.702
View more
  1 in total

1.  Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancer.

Authors:  Ted A Skolarus; Jane Forman; Jordan B Sparks; Tabitha Metreger; Sarah T Hawley; Megan V Caram; Lesly Dossett; Alan Paniagua-Cruz; Danil V Makarov; John T Leppert; Jeremy B Shelton; Kristian D Stensland; Brent K Hollenbeck; Vahakn Shahinian; Anne E Sales; Daniela A Wittmann
Journal:  Implement Sci Commun       Date:  2021-10-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.